Our team

Powered by people.
United by purpose.

Ketotic Hypoglycemia International is a global, volunteer-run organization built by the very people who understand the challenges of Ketotic Hypoglycemia from every perspective.

Different backgrounds.
Different expertise.
One shared mission.

Our team brings together parents and caregivers with physicians, healthcare professionals, scientists, researchers, and advocates from around the world, all united by a shared commitment to improving the lives of individuals and families affected by Ketotic Hypoglycemia.

What began as families searching for answers has grown into a patient-led international community helping connect lived experience with scientific expertise.

Familieshelp identify the questions that need to be answered.
Physiciansand healthcare professionals bring clinical knowledge and experience.
Researchershelp transform observations into evidence and discovery.
Togetherwe work to advance understanding of KH, improve education and clinical care, support meaningful research, and ensure that the patient and family voice remains at the center of progress.
Leadership

Leading KHI

Danielle Drachmann

Danielle Drachmann

Founder and President

Danielle Drachmann is the Founder and President of Ketotic Hypoglycemia International (KHI), a global patient-led organization advancing the understanding, research, recognition, and care of Ketotic Hypoglycemia (KH).

Her leadership is rooted in both lived experience and scientific inquiry. After Danielle and her children were diagnosed with Idiopathic Ketotic Hypoglycemia (IKH), she recognized significant gaps in clinical knowledge, research, and patient support. Rather than accepting those gaps, she built KHI to bring patients, caregivers, physicians, researchers, and healthcare leaders together to help answer questions that had remained largely unexplored for decades.

With a Master’s degree in Anthropology of Health, Danielle has become a leading voice in patient-driven research and rare disease advocacy. She has helped establish a model in which lived experience is transformed into research questions, patient observations inform scientific investigation, and families become active partners in advancing medical knowledge.

Danielle is a published co-author of multiple peer-reviewed scientific publications on Ketotic Hypoglycemia. Her work includes the landmark Orphanet Journal of Rare Diseases publication, “Towards Enhanced Understanding of Idiopathic Ketotic Hypoglycemia,” which helped establish a framework distinguishing physiological from pathological Ketotic Hypoglycemia and formally introduced KHI to the scientific community. She subsequently co-authored research identifying Ketotic Hypoglycemia in individuals with Down syndrome and contributed to “Idiopathic Pathological Ketotic Hypoglycemia: Finding the Needle in a Haystack,” advancing the scientific conversation around severe, recurrent, and unexplained forms of KH.

Her work extends beyond publication. Danielle has contributed to international rare disease policy and patient engagement initiatives, represented patient perspectives within European healthcare discussions, and championed citizen science as a mechanism for accelerating discovery in underrecognized conditions.

Through KHI, Danielle continues to build international collaboration among families, pediatric endocrinologists, metabolic specialists, geneticists, researchers, healthcare institutions, and rare disease partners. Her leadership is helping move Ketotic Hypoglycemia from an often-overlooked clinical presentation toward a field of growing scientific investigation.

Danielle’s vision for KHI is clear: bring patients and science together to ask better questions, generate stronger evidence, improve clinical understanding, and ultimately create better outcomes for every person affected by Ketotic Hypoglycemia.

Amanda Roser

Amanda Roser

Chief Executive Officer (CEO)

Amanda Roser serves as Chief Executive Officer of Ketotic Hypoglycemia International (KHI), working alongside Founder and President Danielle Drachmann to lead the organization’s strategic growth and expand its global impact across research, education, advocacy, and patient support.

Amanda brings more than 18 years of marketing and business leadership experience, with extensive expertise in healthcare and medical device marketing, organizational growth, strategic partnerships, digital strategy, communications, and stakeholder engagement. As Vice President of Marketing and Operations at Social Strategy1, she has led multidisciplinary teams and growth initiatives for healthcare organizations and medical technology companies, providing her with a strong understanding of both the business and clinical healthcare environments.

Her leadership at KHI is also informed by lived experience. Amanda’s son, Christopher, developed severe Ketotic Hypoglycemia as a toddler, beginning a complex diagnostic and medical journey that exposed her firsthand to the challenges families face when navigating an underrecognized metabolic condition.

Amanda initially brought her professional expertise to KHI as a volunteer heading up marketing and has since transitioned into executive leadership. As CEO, she is focused on strengthening KHI’s organizational infrastructure, developing strategic and industry partnerships, expanding scientific and clinical education, increasing global awareness, supporting research collaboration, and creating stronger connections among patients, caregivers, physicians, researchers, healthcare institutions, and industry.

Together with Danielle and KHI’s international network of medical and scientific advisors, Amanda is helping position KHI for its next phase of growth, building a sustainable organization capable of accelerating research, improving clinical understanding, and creating meaningful, measurable impact for individuals and families affected by Ketotic Hypoglycemia worldwide.

Nick Ben

Nick Ben

Head of Marketing

Nick leads KHI’s communication. He ghostwrites the speeches, designs the presentations and prepares Danielle Drachmann for the political and scientific events she speaks at, most recently the European Parliament’s hearing on advanced therapies in November 2026.

He also built this website. In his day job, Nick works in affiliate and partner marketing.

Scientific Advisory Board

Patient power, people power, parent power

With the passion and dedication from the families, we are able to unite the medical experts and lead them towards our need for research, and partner in the process of the research being conducted. To us, the narratives of the families act as a leading star in everything we do, and everything we initiate. We are able to engage industry partners with our medical experts, with the patients and families at the center.

KHI works as a patient-led research facilitator, bringing medical experts from across the globe to work alongside patients and caregivers in every step of the research process, from conception to publication.

What is a Scientific Advisory Board? An advisory board is a structured and collaborative method for organizations to engage with external advisors. Advisory boards act as a sounding board for either the owners, directors, or shareholders of a company or in this case, an organization.
Current members

Meet the board

David A. Weinstein

David A. Weinstein

Passage Bio

World-famous, award-winning, and knighted MD & professor, leading research in the field of GSD and ketotic hypoglycemia for decades. Lead for the GM1 gangliosidosis gene therapy trial at Passage Bio.

  • Former director, GSD program
  • Order of The Smile award
  • Passage Bio, Philadelphia, United States
Paul Thornton

Paul Thornton

Cook Children’s Medical Center

Award-winning medical director specialized in hyperinsulinism, Distinguished Consultant of the Endocrinology/Diabetes Clinic, and the Hyperinsulinism Center at Cook Children’s Medical Center.

  • Medical director
  • Pediatric endocrinology
  • Cook Children’s Medical Center, Fort Worth, Texas, United States
Terry Derks

Terry Derks

UMCG

Leading expert in Inborn errors of metabolism. Neonatal screening Hepatic glycogen storage diseases. Medium-chain acyl-CoA dehydrogenase deficiency, multiple acyl-CoA dehydrogenase deficiency.

  • WP-lead, MetabERN
  • Inborn error of metabolism
  • Beatrix Children’s Hospital, Groningen, The Netherlands
Pratik Shah

Pratik Shah

The Royal London Children’s Hospital

Consultant in Pediatric Endocrinology and Honorary Senior Lecturer, specialized in glucose disorders. Has led a highly specialized service for Congenital Hyperinsulinism.

  • PhD in Congenital HI
  • Children with glucose disorders
  • The Royal London Children’s Hospital, London, UK
Joseph Wolfsdorf

Joseph Wolfsdorf

Boston Children’s Hospital

Professor of Pediatrics at Harvard Medical School, first incumbent of the Boston Children’s Hospital Chair in Endocrinology. Served as Director of the Diabetes Program at Boston Children’s Hospital for 35 years.

  • Clinical director
  • Pediatric endocrinology
  • Children’s Hospital Boston, Boston, United States
Mary-Elizabeth Patti

Mary-Elizabeth Patti

Joslin Diabetes Center

Investigator and Staff Physician, Director, Hypoglycemia Clinic, Co-Director, Molecular Phenotyping and Genotyping Core, Associate Professor of Medicine, Harvard Medical School

  • Director and PI
  • Adult endocrinology
  • Joslin Diabetes Center, Boston, United States
Get involved

Help us do more

Everything KHI has built so far was built by volunteers, without major funding. Your support helps us keep going.

Emerging Researchers Board

The next generation of hypoglycemia research

The emerging researchers board is a united group of emerging researchers in the field of complex hypoglycemia and ketotic hypoglycemia from around the globe.

Anne Benner

Anne Benner

Pediatric endocrinology

I am a doctor with a great interest in pediatric endocrinology. For over four years I have learned more and more about ketotic hypoglycemia because I met the great professor Henrik Thybo Christesen. I started doing research with him in the field of children with ketotic hypoglycemia. I found Henrik to be an inspiration and now see him as a mentor.

In KHI, I found the possibility to hear out the patients and families, and I found co-creation to be an asset to scientific research. I am honored to be a part of the Emerging Researchers Board.

Alessandro Rossi

Alessandro Rossi

University of Naples Federico II · University of Groningen

Alessandro Rossi currently works at the Department of Translational Medicine, University of Naples Federico II and Department of Pediatrics, University of Groningen. Alessandro does research in Inherited Metabolic Disease, Diabetology and Pediatrics.

Some of the most recent publications are:

AV

Annieke Venema

University Medical Centre Groningen

Affiliation: Department of Metabolic Diseases, Beatrix Children’s Hospital, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands

Latest publication:

Azizun Nessa

Azizun Nessa

Emerging researcher

Bio coming soon.

Elizabeth Rosenfeld

Elizabeth Rosenfeld

Children’s Hospital of Philadelphia

Dr. Elizabeth Rosenfeld is a pediatric endocrinologist in the Division of Endocrinology and Diabetes at the Children’s Hospital of Philadelphia. She specializes in the diagnosis and management of hypoglycemia disorders.

Read more

Dr. Rosenfeld is a physician-scientist and directs an actively funded clinical research program. Her research focuses on using innovative neuroimaging techniques to advance understanding of how hypoglycemia affects brain development and function. Her aim is to improve neurocognitive outcomes for children with hypoglycemia disorders. She is passionate about learning from patients, families, and colleagues and is honored to be joining the Emerging Researchers Board. Participation on this board will facilitate international collaboration and growth to broaden understanding of hypoglycemia disorders, and ultimately, improve the lives of children and families with ketotic hypoglycemia.

Erin Okawa

Erin Okawa

UCLA · Director, Hyperinsulinism Program

Dr. Okawa is a Health Sciences Clinical Assistant Professor at the David Geffen School of Medicine at UCLA; she is also the Director of the Hyperinsulinism Program.

Read more

She received B.A. degrees in both biology and communication at the University of Pennsylvania in Philadelphia. She then received her M.D. degree from the Sidney Kimmel Medical College (formerly Jefferson Medical College), also in Philadelphia. She completed her residency in Pediatrics at Kaiser Permanente Los Angeles Medical Center and her fellowship in Pediatric Endocrinology at Harvard-affiliated Boston Children’s Hospital and the Joslin Diabetes Center. Her clinical interests include type 1 diabetes, monogenic diabetes, and hyperinsulinism.

William (Bill) Brucker

William (Bill) Brucker

Hasbro Children’s Hospital

I am a biochemical geneticist working at Hasbro Children’s Hospital in Providence, Rhode Island. Idiopathic ketotic hypoglycemia is a disease entity that I have been interested in since my time in fellowship at Boston Children’s Hospital.

Read more

I was fortunate to have both great metabolic and endocrine mentors who helped me recognize that IKH had a metabolic component and was a disorder of catabolic insufficiency where the flow of gluconeogenic amino acids decreased to the degree that blood glucose levels became unstable during stress states and that some affected individuals did have a glycogen storage disease component. Unlike traditional disorders of decompensating metabolism, there is no newborn screen to identify who may or may not be at risk for this physiology. It is also markedly more common than any individual metabolic disorder. I have a lot of empathy for the families affected by this physiology as it is severe and unpredictable and often leads to the recurrent utilization of both emergency services and inpatient admissions. I was very excited to be invited to join the Emerging Researchers Board at KHI to work with a dedicated group of individuals to develop better ways to mitigate this common and dangerous disease process.

Komal Parmar

Komal Parmar

Emerging researcher

Bio coming soon.

MD

Monika Dambska

Emerging researcher

Bio coming soon.

Get involved

Help us do more

Everything KHI has built so far was built by volunteers, without major funding. Your support helps us keep going.

Get involved

Help us do more

Everything KHI has built so far was built by volunteers, without major funding. Your support helps us keep going.

Log In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections

Here you'll find all collections you've created before.